STOCK-BASED EMPLOYEE COMPENSATION (Details) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended					3 Months Ended		0 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014 Selling, General and Administrative Expenses [Member]	Mar. 31, 2013 Selling, General and Administrative Expenses [Member]	Mar. 31, 2014 Stock Options [Member]	Mar. 31, 2014 2013 Equity Incentive Plan [Member]	Feb. 27, 2013 2013 Equity Incentive Plan [Member]	Feb. 27, 2013 2013 Equity Incentive Plan [Member] Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock authorized for issuance (in shares)							2,600,000
Options granted exercise right period								10 years
Stockholder ownership classification, for exercise price conditions (in hundredths)								10.00%
10% Stockholder exercise price of any option to fair value of common shares (in hundredths)								110.00%
Issuance of common stock (in shares)	7					7,000
Stock options granted (in shares)	0							850,000
Stock options, grants in period, exercise price (in dollars per share)	$ 0							$ 0.26
Grant date fair value								$ 151
Stock options exercisable period	9 years							2 years
Stock options expiration date								Feb. 27, 2023
Option awards vesting on the date of issuance, 1 year after issuance and 2 years after issuance, respectively (in hundredths)								33.33%
Stock-based compensation expense			13	55
Number of options exercisable (in shares)						7,000
Intrinsic value of shares exercised						4
Common stock available for future issuance (in shares)					1,695,000
Assumptions used in estimating fair values of options granted [Abstract]
Expected volatility (in hundredths)		84.00%
Expected dividend yield (in hundredths)		0.00%
Weighted average risk-free interest rate (in hundredths)		1.05%
Expected life		5 years 6 months
Forfeiture rate (in hundredths)		0.00%
Unrecognized stock compensation expense	54
Unrecognized stock compensation expense (in years)	1 year
Number of Shares [Roll Forward]
Outstanding, Beginning balance (in shares)	905
Grants (in shares)	0							850,000
Exercised (in shares)	(7)					(7,000)
Forfeited, cancelled or expired (in shares)	0
Outstanding, Ending balance (in shares)	898
Exercisable (in shares)	583
Weighted Average Exercise Price [Roll Forward]
Outstanding, Beginning balance (in dollars per share)	$ 0.28
Grants (in dollars per share)	$ 0							$ 0.26
Exercised (in dollars per share)	$ (0.54)
Forfeited, cancelled or expired (in dollars per share)	$ 0
Outstanding, Ending balance (in dollars per share)	$ 0.28
Exercisable (in dollars per share)	$ 0.27
Options, Additional Disclosures [Abstract]
Outstanding, Remaining Contractual Life (in years)	9 years
Exercisable, Remaining Contractual Life (in years)	9 years							2 years
Outstanding, Aggregate Intrinsic Value	1,181
Exercisable, Aggregate Intrinsic Value	$ 770